Charles River Laboratories (CRL) Equity Notice: Contact Robbins LLP if you are a Shareholder Who Suffered Significant Losses in Charles River Laboratories International, Inc.
June 14, 2023 18:13 ET
|
Robbins LLP
SAN DIEGO, June 14, 2023 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action against Charles River Laboratories International, Inc. (NYSE: CRL) for...
Charles River Laboratories International, Inc. (CRL) Equity Alert: Robbins LLP Urges Charles River Laboratories International, Inc. Investors to Contact the Firm
June 09, 2023 12:16 ET
|
Robbins LLP
SAN DIEGO, June 09, 2023 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action against Charles River Laboratories International, Inc. (NYSE: CRL) for wrongdoing...
Charles River Laboratories International, Inc. (CRL) Shareholder Alert: Robbins LLP Reminds Investors of Class Action Against Charles River Laboratories International, Inc.
May 26, 2023 14:48 ET
|
Robbins LLP
SAN DIEGO, May 26, 2023 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of persons or entities who purchased or otherwise acquired Charles River...